“ The primary reasons Advent was started were:
(1) Convince the EMA and MHRA that NWBio would be able to produce enough DCVax-L, on a commercial scale, to justify regulatory approval of DCVax-L in the UK, Germany and the rest of the EU.
(2) Protect the DCVax-L and DCVax Direct patents and other IP from rivals, and potential rivals, in Europe including Big Pharma. ”
This is PURE SPECULATION on your part and nothing more!!!
Pumpernickel YuYU... YuYU..LaYuLaYuYuuuuuuuuuu...AAAAAAAAAAAAAAAAAAAAAAAWWWWWWWWWWWHHHHHHHHHHHHHHHHOOOOOOOOOOOOOOOOooooooooooooooooeeeeeeeeeeeeeeeeeeee!!!!!!